Central nervous system excitatory effects of meperidine in cancer patients
β Scribed by Dr Robert F. Kaiko; Kathleen M. Foley; Patricia Y. Grabinski; George Heidrich; Ada G. Rogers; Charles E. Inturrisi; Marcus M. Reidenberg
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 578 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. The possibility of tumor sanctuary sites in the central nervous system (CNS) of patients receiving paclitaxel has been suggested by laboratory data identifying low concentrations of drug in the brain and cerebrospinal fluid (CSF) of rats. Methods. The pattern of disease progression in p
## Abstract ## BACKGROUND Venous thromboembolism (VTE) is a frequent complication in patients with cancer throughout the course of the disease. Patients with brain tumors are at particularly high risk for VTE, and several risk factors were found in patients with malignant glioma. To the authors' k
## Abstract ## BACKGROUND. Breast cancer is the second most common cause of central nervous system (CNS) metastases. Several risk factors for CNS metastases have been reported. The objective of the current study was to describe clinicopathologic characteristics and prognostic factors in breast can
Ubiquitin (Ub) modification of different proteins plays an important role in many cellular processes. However, the best studied function of Ub is the labeling of proteins committed to rapid degradation, by an ATPdependent pathway. We previously found that this pathway is operative in the central ner
Hypericum species have been used as herbal remedies for the therapy of various neurological disorders. In the present study, the efTects of Hypericum culycinum on the central nervous system were investigated using various behavioural models including swimming time, locomotor activity, tail-flick and